Skip to content

Immune Profile and Respiratory Parameters in Down Syndrome Children With Acute Pneumonia: Pre-Intervention Analysis

Relationship Between Immune Profile and Respiratory Parameters in Down Syndrome Children With Acute Pneumonia: Pre-Intervention Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07366593
Enrollment
40
Registered
2026-01-26
Start date
2025-07-01
Completion date
2026-01-30
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Keywords

Down Syndrome, pneumonia, immune, oxygen saturation

Brief summary

Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age

Detailed description

descriptive, cross-sectional study analyzed baseline data from 40 children with DS and acute pneumonia enrolled prior to intervention in a larger trial. Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age.

Interventions

PROCEDUREPearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age

Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age.

Sponsors

Badr University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* Down Syndrome with acute bronchopneumonia * sufficient cognitive ability

Exclusion criteria

* severe congenital heart defects * primary immunodeficiencies

Design outcomes

Primary

MeasureTime frameDescription
serum IgG, IgA, IgMUpon enrollment and prior to any intervention baseline data were collectedImmunoglobulins: Concentrations of IgG(mg/dl) IgA,(mg/dl) and IgM (mg/dl) were determined from serum using an automated nephelometer
Respiratory RateUpon enrollment and prior to any intervention baseline data were collectedRespiratory rate (breaths/minute) was determined by direct observation and counting of chest wall movements over one full minute
Arterial Oxygen Saturation (SaO2)Upon enrollment and prior to any intervention baseline data were collectedPeripheral oxygen saturation (%) was measured non-invasively via pulse oximetry
White Blood Cell countUpon enrollment and prior to any intervention baseline data were collectedTotal WBC count (thousands/mm³) was measured from a whole blood sample using an ADVIA 120 automated hematology analyzer

Countries

Egypt

Contacts

CONTACTMona Mohamed Abdelkhalek, assistance prof
3m.sons@gmail.com002021024056108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026